A comprehensive perspective on the interaction between gut microbiota and COVID-19 vaccines

被引:9
作者
Hong, Ming [1 ]
Lan, Tin [1 ]
Li, Qiuxia [1 ]
Li, Binfei [2 ]
Yuan, Yong [3 ,5 ]
Xu, Feng [4 ,6 ]
Wang, Weijia [1 ,7 ]
机构
[1] Zhongshan City Peoples Hosp, Inst Adv Diagnost & Clin Med, Zhongshan, Peoples R China
[2] Zhongshan City Peoples Hosp, Dept Anesthesiol, Zhongshan, Peoples R China
[3] Zhongshan City Peoples Hosp, Dept Cardiovasc Ctr, Zhongshan, Peoples R China
[4] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC, Canada
[5] Zhongshan City Peoples Hosp, Dept Cardiovasc Ctr, Zhongshan 528400, Peoples R China
[6] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V6Z 1Y6, Canada
[7] Zhongshan City Peoples Hosp, Inst Adv Diagnost & Clin Med, Zhongshan 528400, Peoples R China
关键词
COVID-19; vaccine efficacy; gut microbiota; immune responses; microbiota-targeted interventions; AUTOIMMUNITY; VACCINATION; RESPONSES; IMMUNITY; HEALTH; CELLS; YOUNG;
D O I
10.1080/19490976.2023.2233146
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The efficacy of COVID-19 vaccines varies between individuals and populations, and the reasons for this are still not fully understood. Recent clinical studies and animal models have indicated that the gut microbiota may influence the immunogenicity of the vaccine and, thus, its effectiveness. This suggests that there is a bidirectional relationship between the gut microbiota and the COVID-19 vaccine, with the varying components of the microbiota either enhancing or reducing the vaccine's efficacy. To put an end to the spread of the COVID-19 pandemic, the necessity of vaccines that create powerful and long-term immunity is now more important than ever, and understanding the role of the gut microbiota in this process is essential. Conversely, COVID-19 vaccines also have a significant effect on the gut microbiota, decreasing its total number of organisms and the variety of species present. In this Review, we analyze the evidence that suggesting an interaction between the gut microbiota and COVID-19 vaccine effectiveness, consider the immunological mechanisms that may be responsible for this connection, and explore the possibility of using gut microbiota-focused interventions to improve the efficacy of COVID-19 vaccines.
引用
收藏
页数:33
相关论文
共 121 条
  • [1] Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design study
    Adams, Katherine
    Rhoads, Jillian P.
    Surie, Diya
    Gaglani, Manjusha
    Ginde, Adit A.
    McNeal, Tresa
    Talbot, H. Keipp
    Casey, Jonathan D.
    Zepeski, Anne
    Shapiro, Nathan, I
    Gibbs, Kevin W.
    Files, D. Clark
    Hager, David N.
    Frosch, Anne E.
    Exline, Matthew C.
    Mohamed, Amira
    Johnson, Nicholas J.
    Steingrub, Jay S.
    Peltan, Ithan D.
    Brown, Samuel M.
    Martin, Emily T.
    Lauring, Adam S.
    Khan, Akram
    Busse, Laurence W.
    Duggal, Abhijit
    Wilson, Jennifer G.
    Chang, Steven Y.
    Mallow, Christopher
    Kwon, Jennie H.
    Chappell, James D.
    Halasa, Natasha
    Grijalva, Carlos G.
    Lindsell, Christopher J.
    Lester, Sandra N.
    Thornburg, Natalie J.
    Park, SoHee
    McMorrow, Meredith L.
    Patel, Manish M.
    Tenforde, Mark W.
    Self, Wesley H.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
  • [2] Who wants his dose?
    不详
    [J]. EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2023, (193): : 239 - 240
  • [3] Infection and Immune Memory: Variables in Robust Protection by Vaccines Against SARS-CoV-2
    Ahluwalia, Pankaj
    Vaibhav, Kumar
    Ahluwalia, Meenakshi
    Mondal, Ashis K.
    Sahajpal, Nikhil
    Rojiani, Amyn M.
    Kolhe, Ravindra
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [4] The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients
    Alexander, James L.
    Mullish, Benjamin H.
    Danckert, Nathan P.
    Liu, Zhigang
    Olbei, Marton L.
    Saifuddin, Aamir
    Torkizadeh, Melissa
    Ibraheim, Hajir
    Blanco, Jesus Miguens
    Roberts, Lauren A.
    Bewshea, Claire M.
    Nice, Rachel
    Lin, Simeng
    Prabhudev, Hemanth
    Sands, Caroline
    Horneffer-van der Sluis, Verena
    Lewis, Matthew
    Sebastian, Shaji
    Lees, Charlie W.
    Teare, Julian P.
    Hart, Ailsa
    Goodhand, James R.
    Kennedy, Nicholas A.
    Korcsmaros, Tamas
    Marchesi, Julian R.
    Ahmad, Tariq
    Powell, Nick
    [J]. EBIOMEDICINE, 2023, 88
  • [5] Immune Impairment Associated with Vitamin A Deficiency: Insights from Clinical Studies and Animal Model Research
    Amimo, Joshua O.
    Michael, Husheem
    Chepngeno, Juliet
    Raev, Sergei A.
    Saif, Linda J.
    Vlasova, Anastasia N.
    [J]. NUTRIENTS, 2022, 14 (23)
  • [6] Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19
    Amrouche, T.
    Chikindas, M. L.
    [J]. AIMS MICROBIOLOGY, 2022, 8 (03): : 338 - 356
  • [7] Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
    Antunes, Krist Helen
    Cassao, Gisele
    Santos, Leonardo Duarte
    Borges, Sofia Giacomet
    Poppe, Juliana
    Goncalves, Joao Budelon
    Nunes, Eduarda da Silva
    Recacho, Guilherme Fernando
    Sousa, Vitoria Barbosa
    Da Silva, Gabriela Souza
    Mansur, Daniel
    Stein, Renato T.
    Pasquali, Christian
    De Souza, Ana Paula Duarte
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [8] Durability of immune responses to mRNA booster vaccination against COVID-19
    Arunachalam, Prabhu S.
    Lai, Lilin
    Samaha, Hady
    Feng, Yupeng
    Hu, Mengyun
    Hui, Harold Sai-yin
    Wali, Bushra
    Ellis, Madison
    Davis-Gardner, Meredith E.
    Huerta, Christopher
    Bechnak, Kareem
    Bechnak, Sarah
    Lee, Matthew
    Litvack, Matthew B.
    Losada, Cecilia
    Grifoni, Alba
    Sette, Alessandro
    Zarnitsyna, Veronika I.
    Rouphael, Nadine
    Suthar, Mehul S.
    Pulendran, Bali
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (10)
  • [9] Arunachalam PS., 2022, DURABILITY IMMUNE RE, V12, P22282921
  • [10] Exposure to a social stressor alters the structure of the intestinal microbiota: Implications for stressor-induced immunomodulation
    Bailey, Michael T.
    Dowd, Scot E.
    Galley, Jeffrey D.
    Hufnagle, Amy R.
    Allen, Rebecca G.
    Lyte, Mark
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2011, 25 (03) : 397 - 407